Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Wednesday, December 23, 2009, 12:48PM ET - U.S. Markets close in 3 hours and 12 minutes. Dow Down 0.01% Nasdaq Up 0.53%
Valeant Pharmaceuticals International (VRX)At 12:32PM ET: 32.67  Down 0.06 (0.18%)  
MORE ON VRX
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
PERIOD ENDING31-Dec-0831-Dec-0731-Dec-06
Total Revenue656,977  872,222  907,238  
Cost of Revenue167,916  233,094  256,980  
Gross Profit489,061  639,128  650,258  
Operating Expenses
Research Development86,967  98,025  109,618  
Selling General and Administrative278,019  371,045  382,006  
Non Recurring207,595  23,176  86,631  
Others49,973  71,567  71,876  
Total Operating Expenses622,554  563,813  650,131  
Operating Income or Loss(133,493)75,315  127  
Income from Continuing Operations
Total Other Income/Expenses Net7,637  18,852  13,762  
Earnings Before Interest And Taxes(125,856)94,167  13,889  
Interest Expense30,486  42,878  43,726  
Income Before Tax(156,342)51,289  (29,837)
Income Tax Expense33,913  25,233  34,219  
Minority Interest(7)(2)(3)
Net Income From Continuing Ops(190,262)26,054  (64,059)
Non-recurring Events
Discontinued Operations166,548  (32,240)7,494  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income(23,714)(6,186)(56,565)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares($23,714)($6,186)($56,565)

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol: Symbol Lookup
Sector Analysis

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More